Celltrion
068270.KS
#811
Rank
ยฃ21.52 B
Marketcap
ยฃ95.70
Share price
2.07%
Change (1 day)
8.80%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): ยฃ0.82

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ0.80. In 2023 the company made an earnings per share (EPS) of ยฃ2.08 a decrease over its 2022 EPS that were of ยฃ2.12.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.82
2023ยฃ2.08-2.08%
2022ยฃ2.12-11.72%
2021ยฃ2.402.03%
2020ยฃ2.3582.8%
2019ยฃ1.2918.31%
2018ยฃ1.09-36.33%
2017ยฃ1.71161.25%
2016ยฃ0.652.86%
2015ยฃ0.6417.84%
2014ยฃ0.545.87%
2013ยฃ0.51-70.85%
2012ยฃ1.75134.09%
2011ยฃ0.7543.59%
2010ยฃ0.5274.49%
2009ยฃ0.30317.8%
2008ยฃ0.07139-71.7%
2007ยฃ0.25